GlassScriptPhysician profile
Carl M Gauthier
NPI 1649460239
$218,786.38
in general payments reported to CMS, 2019-2025
31 companies · $35K in 2025
The $35K reported for 2025 was more than what 95% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $10K · 2021: $26K · 2022: $46K · 2023: $18K · 2024: $21K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Food and Beverage: $5,596 · Consulting Fee: $5,200 · Travel and Lodging: $1,918 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,562.50 |
| Food and Beverage | $5,596.41 |
| Consulting Fee | $5,200.00 |
| Travel and Lodging | $1,917.50 |
| Education | $188.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $100,200.16 | 2019-2025 | |
| Amgen INC. | $63,718.87 | 2019-2025 | Otezla, Otezla, Enbrel |
| Novartis Pharmaceuticals Corporation | $17,775.30 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $11,413.46 | 2019-2020 | |
| Celgene Corporation | $10,938.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $6,549.12 | 2019-2025 | Orencia, Sotyktu |
| Genzyme Corporation | $4,368.69 | 2020-2021 | |
| Ucb, INC. | $812.97 | 2019-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $444.43 | 2019-2025 | Tremfya |
| Pfizer INC. | $411.43 | 2019-2025 | |
| Lilly USA, LLC | $342.22 | 2019-2024 | Taltz |
| Glaxosmithkline, LLC. | $290.01 | 2019-2025 | Benlysta |
| Horizon Therapeutics Plc | $279.11 | 2019-2023 | Krystexxa |
| Mallinckrodt Enterprises LLC | $212.67 | 2019 | |
| Mallinckrodt Hospital Products INC. | $136.28 | 2020-2023 | Acthar |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $135.16 | 2019-2025 | Actemra |
| Fresenius Kabi USA, LLC | $122.03 | 2023-2025 | Idacio |
| Organon LLC | $89.55 | 2023-2025 | Hadlima |
| Radius Health, INC. | $87.61 | 2020-2025 | Tymlos |
| Hikma Pharmaceuticals USA | $82.45 | 2019 | |
| Alexion Pharmaceuticals, INC. | $71.46 | 2019-2025 | Strensiq |
| Antares Pharma, INC. | $66.54 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $43.22 | 2024-2025 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.29 | 2024 | Ofev, Cyltezo |
| Oyster Point Pharma, INC. | $30.32 | 2023 | Tyrvaya |
| Valinor Pharma, LLC | $25.16 | 2024 | Movantik |
| Takeda Pharmaceuticals U.S.A., INC. | $23.33 | 2020 | |
| Baxter Healthcare | $22.52 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Pacira Therapeutics, INC. | $20.71 | 2019 | |
| Sandoz INC. | $19.24 | 2024 | Hyrimoz |
| Scilex Pharmaceuticals INC. | $17.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Gauthier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.